Author: Dr Val Phua
Estimated reading time: 10–12 minutes
Omega-3 Is Widely Recommended—but the Evidence Is Mixed
Omega-3 supplements are frequently promoted as a natural treatment for dry eye disease and meibomian gland dysfunction.
The proposed benefits sound convincing. Omega-3 fatty acids are involved in cell membranes and inflammatory signalling, while healthy eyelid oil is essential for reducing tear evaporation.
However, scientific studies have produced conflicting results.
Some clinical trials and meta-analyses have reported improvements in dry-eye symptoms, tear stability or meibomian gland function. In contrast, several large, well-designed randomised trials found that omega-3 supplements were no more effective than comparison oils or placebo. There is also no agreed dosage, formulation or duration of treatment specifically for dry eye.
The most accurate conclusion is:
Omega-3 supplements may help some patients, but they are not a proven or universally effective treatment for dry eye.
What Are Omega-3 Fatty Acids?
Omega-3 fatty acids are polyunsaturated fats found in certain foods and supplements.
The three main forms are:
Alpha-Linolenic Acid
Alpha-linolenic acid, or ALA, is found mainly in plant foods such as:
- Flaxseed
- Chia seeds
- Walnuts
- Soybean oil
- Canola oil
The body can convert ALA into the longer-chain omega-3 fatty acids EPA and DHA, but this conversion is limited.
Eicosapentaenoic Acid
Eicosapentaenoic acid, or EPA, is found mainly in:
- Oily fish
- Fish-oil supplements
- Krill oil
- Certain algae-derived products
EPA is involved in pathways that influence inflammation and immune signalling.
Docosahexaenoic Acid
Docosahexaenoic acid, or DHA, is an important component of cell membranes and is found in high concentrations within the retina and brain.
DHA is present in oily fish, fish oil and certain algae-derived supplements.
Most dry-eye studies have examined supplements containing combinations of EPA and DHA, rather than plant-based ALA alone.
Why Might Omega-3 Help Dry Eye?
Researchers have proposed several possible mechanisms.
Modifying Inflammatory Signalling
Dry-eye disease frequently involves inflammation of the tear film, ocular surface and eyelid glands.
EPA and DHA participate in the production of signalling molecules that may favour less inflammatory activity. However, the relationship between dietary fats and inflammation is complex, and an ideal omega-6-to-omega-3 ratio has not been established.
Supporting Meibomian Gland Secretions
The meibomian glands produce the oily outer layer of the tear film.
Researchers have proposed that omega-3 intake may alter the composition or flow of meibomian gland oil, helping reduce tear evaporation.
This is one reason omega-3 supplements are often recommended for patients with evaporative dry eye or meibomian gland dysfunction.
Improving Tear-Film Stability
Some smaller studies have reported improvements in:
- Tear-breakup time
- Tear osmolarity
- Ocular-surface staining
- Dry-eye symptom scores
- Meibomian gland secretion quality
However, these results have not been reproduced consistently across larger trials.
What Did the DREAM Trial Find?
The Dry Eye Assessment and Management study—known as the DREAM trial—was one of the largest and most influential studies of omega-3 supplementation for dry eye.
Participants with moderate-to-severe dry-eye disease received either:
- 3,000 mg of EPA and DHA daily, or
- An olive-oil placebo
After 12 months, both groups reported improvement, but omega-3 supplementation was not significantly better than placebo for relieving dry-eye symptoms or improving the main clinical signs.
A subsequent extension of the DREAM study also failed to demonstrate a measurable benefit from continuing omega-3 supplementation compared with stopping it.
These findings do not prove that omega-3 can never help an individual patient. They do, however, mean that routine high-dose supplementation cannot be confidently recommended as an effective treatment for all patients with dry eye.
What Did the More Recent MGD Trial Find?
A 2024 randomised clinical trial studied re-esterified triglyceride omega-3 supplements in patients with dry eye associated with meibomian gland dysfunction.
The trial included 132 patients and compared omega-3 supplementation with grape-seed oil.
After six and twelve weeks, the omega-3 group was not superior for improving dry-eye symptoms. The authors concluded that the findings did not support routine use of this omega-3 formulation solely for relieving MGD-related dry-eye symptoms.
This is important because re-esterified triglyceride formulations are sometimes marketed as having better absorption and therefore greater clinical effectiveness.
While some omega-3 forms may have somewhat different bioavailability, better absorption does not automatically mean proven improvement in dry-eye symptoms.
Why Do Some Reviews Still Report a Benefit?
Several meta-analyses have concluded that omega-3 supplements may improve dry-eye symptoms or selected tear-film measurements.
However, the included studies differ greatly in:
- Patient characteristics
- Type of dry eye
- Omega-3 formulation
- EPA-to-DHA ratio
- Daily dosage
- Duration of treatment
- Comparison oil
- Additional dry-eye treatments
- Methods used to measure improvement
When studies are this different, combining them may produce an average result that does not apply reliably to every patient.
A 2023 meta-analysis reported potential benefits, particularly with higher EPA content, longer treatment duration and higher doses, but also emphasised substantial variation between studies and the need for caution when generalising the findings.
Current TFOS DEWS III guidance therefore treats nutrition as part of broader dry-eye management rather than presenting omega-3 capsules as a stand-alone cure.
Does Omega-3 Prevent Dry Eye?
Omega-3 supplements have not been shown convincingly to prevent dry-eye disease in people without significant symptoms.
A large ancillary study of the VITAL trial followed more than 23,000 adults for a median of over five years. Daily omega-3 supplementation did not significantly prevent new dry-eye diagnoses or severe dry-eye symptoms compared with placebo.
Omega-3 should therefore not be taken solely on the assumption that it will prevent dry eye from developing.
Should I Take Omega-3 for Dry Eye?
Omega-3 supplementation may still be considered in selected patients after discussion with their doctor.
It may be reasonable when:
- The patient has a low dietary intake of oily fish.
- Meibomian gland dysfunction is present.
- The patient understands that the evidence is mixed.
- There are no significant contraindications or medication interactions.
- Omega-3 is used as an adjunct rather than replacing proven treatment.
- The response will be reviewed after an appropriate trial period.
It may be less appropriate when:
- The dry eye is caused mainly by severe aqueous tear deficiency.
- The patient has extensive meibomian gland loss.
- There is incomplete eyelid closure.
- Symptoms are caused predominantly by allergy or neuropathic pain.
- The patient expects supplements to replace eyelid care, artificial tears or prescription treatment.
- There is a medical reason to avoid high-dose supplementation.
Omega-3 Should Not Replace Established Dry-Eye Treatment
Depending on the cause of dry eye, more directly targeted treatment may include:
- Preservative-free artificial tears
- Lipid-based lubricants
- Warm compresses
- Eyelid hygiene
- Improved blinking during screen use
- Treatment of blepharitis or Demodex
- Prescription anti-inflammatory eye drops
- Meibomian gland expression
- Thermal treatment
- Intense pulsed light in selected patients
- Treatment of incomplete eyelid closure
- Investigation for Sjögren syndrome or another systemic condition
A supplement is unlikely to overcome untreated gland obstruction, active eyelid inflammation or severe tear deficiency on its own.
Food First: Dietary Sources of Omega-3
For most people, omega-3 is best obtained as part of a balanced diet rather than relying automatically on capsules.
Singapore’s Health Promotion Board advises choosing fish as a protein source at least twice each week. Oily fish such as salmon, sardines, tuna, mackerel and tenggiri contain omega-3 fatty acids.
Other dietary sources include:
- Walnuts
- Chia seeds
- Flaxseeds
- Soybean products
- Canola oil
- Omega-3-enriched foods
Eating fish provides omega-3 alongside protein, vitamins and other nutrients. However, dietary omega-3 should still be viewed as supporting general health rather than as a guaranteed dry-eye treatment.
What About Vegetarian or Vegan Sources?
Plant foods such as flaxseed, chia seeds and walnuts provide ALA.
Because the body converts only a limited proportion of ALA into EPA and DHA, these foods do not provide the same fatty-acid profile as oily fish.
Algae-derived supplements can provide DHA—and in some formulations EPA—directly without fish.
However, the evidence that algae-based omega-3 supplements improve dry eye is also limited. A vegetarian source should not be assumed to be more or less effective without appropriate clinical evidence.
Is Fish Oil Better Than Flaxseed Oil?
Fish oil usually provides EPA and DHA directly.
Flaxseed oil provides mainly ALA, which must be converted by the body into EPA and DHA. As this conversion is limited, flaxseed oil may produce lower long-chain omega-3 levels.
There is insufficient evidence to conclude that flaxseed oil reliably treats dry-eye disease.
Flaxseed oil should never be placed directly into the eye. Only sterile products specifically manufactured and approved for ophthalmic use should be applied to the ocular surface.
Is There a Recommended Omega-3 Dose for Dry Eye?
There is no universally accepted omega-3 dosage for dry-eye treatment.
Clinical trials have used a wide range of doses and EPA-to-DHA combinations.
Examples include:
- Approximately 1,000 mg of combined omega-3 daily
- Approximately 2,240 mg of combined EPA and DHA daily
- 3,000 mg of combined EPA and DHA daily
Both positive and negative studies have used relatively high doses. This means taking more is not necessarily more effective.
Patients should not copy a research-trial dose without medical advice.
Read the Label Carefully
A bottle may state that each capsule contains “1,000 mg fish oil”, but this does not necessarily mean it contains 1,000 mg of EPA and DHA.
The label should state the actual quantities of:
- EPA
- DHA
- Other omega-3 fatty acids
- Number of capsules required for the advertised serving
Comparisons should be made using the actual EPA and DHA content—not simply the total weight of fish oil.
Are Triglyceride-Form Supplements Better?
Omega-3 supplements are available in several forms, including:
- Natural triglycerides
- Ethyl esters
- Re-esterified triglycerides
- Phospholipids
- Free fatty acids
Some triglyceride-based formulations may be absorbed somewhat more efficiently than ethyl esters, particularly under certain dietary conditions. However, all forms can raise blood EPA and DHA levels.
More importantly, improved bioavailability has not yet translated into convincing evidence that one formulation reliably treats dry eye better than another.
How Long Should a Trial Last?
There is no agreed treatment duration.
Studies have ranged from several weeks to one year.
When supplementation is considered, it is reasonable to:
- Define the symptoms being treated.
- Continue established dry-eye care.
- Use a consistent product and dose.
- Review symptoms and clinical signs after an agreed period.
- Stop if there is no meaningful benefit or if side effects occur.
Continuing an expensive supplement indefinitely without assessing whether it helps is unlikely to be useful.
Possible Side Effects
Omega-3 supplements are generally well tolerated, but possible adverse effects include:
- Fishy taste or aftertaste
- Bad breath
- Heartburn
- Nausea
- Abdominal discomfort
- Loose stools or diarrhoea
- Headache
- Unpleasant body odour
These effects are usually mild but may lead patients to discontinue treatment.
Do Omega-3 Supplements Increase Bleeding?
Omega-3 fatty acids can affect platelet activity, particularly at high doses.
Most research has not demonstrated a large increase in clinically significant bleeding with ordinary supplementation, but caution remains appropriate in people taking anticoagulant or antiplatelet medication. Patients taking warfarin or similar drugs should discuss supplementation with their doctor and may require monitoring.
Do not stop prescribed blood-thinning medication in order to take omega-3.
Tell your doctor about supplements before an operation or procedure. Whether they need to be stopped should be decided by the treating clinician rather than assumed.
What About Atrial Fibrillation?
Large cardiovascular trials using approximately 4 grams of omega-3 daily for several years found a small increase in atrial fibrillation among people with cardiovascular disease or a high cardiovascular risk.
Patients with:
- A history of atrial fibrillation
- Palpitations
- Significant cardiovascular disease
- Multiple cardiovascular medications
should discuss high-dose omega-3 supplementation with their doctor before starting it.
Who Should Seek Medical Advice Before Taking Omega-3?
Speak with your doctor or pharmacist if you:
- Take warfarin or another anticoagulant
- Take antiplatelet medication
- Have a bleeding disorder
- Have atrial fibrillation or significant heart disease
- Have a fish or shellfish allergy
- Are pregnant or breastfeeding
- Are preparing for surgery
- Take several medications
- Have liver or other significant medical disease
- Are considering a high-dose product
Supplements can have biological effects and should not automatically be regarded as risk-free.
Choosing a Supplement in Singapore
In Singapore, health supplements are not subject to the same pre-market approval and licensing process as therapeutic medicines. Suppliers remain responsible for product safety and quality, while HSA operates a voluntary notification system for compliant health supplements.
Consumers should:
- Purchase from a reputable local retailer or pharmacy.
- Avoid unfamiliar overseas websites.
- Check the EPA and DHA content.
- Check the expiry date and storage instructions.
- Avoid products making exaggerated claims to cure eye disease.
- Consider whether the product appears on HSA’s voluntary notification list.
- Tell their doctor which supplement they are taking.
HSA advises caution when purchasing health products online from unfamiliar sources because product quality and contents may be uncertain.
Can Omega-3 Cure Meibomian Gland Dysfunction?
No.
Omega-3 supplements cannot reliably:
- Reopen every blocked gland
- Reverse significant gland dropout
- Eliminate blepharitis
- Eradicate Demodex
- Correct incomplete blinking
- Cure rosacea
- Replace gland-directed treatment
At most, omega-3 may serve as one component of a wider treatment plan.
MGD commonly requires:
- Consistent warm compresses
- Eyelid hygiene
- Full and frequent blinking
- Environmental modification
- Artificial tears
- Treatment of inflammation
- In-office treatment where appropriate
When Should Dry Eyes Be Professionally Assessed?
Arrange an eye examination if:
- Symptoms persist despite regular artificial tears.
- Drops are required many times each day.
- Vision frequently fluctuates.
- Contact lenses are becoming uncomfortable.
- The eyelids are red, crusted or tender.
- You have recurrent styes or chalazia.
- One eye is significantly worse.
- Symptoms began or worsened after eye surgery.
- You have dry mouth, joint pain or another autoimmune symptom.
- You are considering omega-3 mainly because your existing treatment is not working.
The next step may be to identify the cause rather than simply add another supplement.
Warning Signs Requiring Prompt Assessment
Dry eye generally causes irritation rather than severe pain or sudden visual loss.
Seek prompt eye care if you develop:
- Significant eye pain
- Sudden or persistent reduction in vision
- Marked light sensitivity
- A white spot on the cornea
- Thick discharge
- Severe or one-sided redness
- Eye injury or chemical exposure
- A painful red eye while wearing contact lenses
These symptoms may indicate infection or another urgent eye condition.
Frequently Asked Questions
Do omega-3 supplements definitely improve dry eye?
No.
Some studies report improvement, but major randomised trials have found no significant advantage over placebo or comparison oils. The overall evidence remains mixed.
Is omega-3 more helpful for MGD than aqueous-deficient dry eye?
It is most commonly proposed for MGD and evaporative dry eye, but recent MGD-specific trials have also produced negative results. It should not be assumed to work simply because MGD is present.
Which is more important: EPA or DHA?
Both have biological roles, but there is no established EPA-to-DHA ratio proven to be best for dry eye.
Is krill oil better than fish oil?
There is insufficient evidence that krill oil provides better dry-eye outcomes than conventional fish oil.
Can I get enough omega-3 from food?
Many people can obtain omega-3 through a balanced diet containing oily fish and plant sources. Singapore HealthHub recommends choosing fish as a protein source at least twice weekly.
Can I take omega-3 with artificial tears?
Generally, yes. Omega-3 supplements are usually used as an adjunct rather than a replacement for artificial tears and other treatment.
How soon should omega-3 improve my symptoms?
There is no reliable timeline. Studies have evaluated treatment over periods ranging from weeks to months. Lack of improvement after a defined trial should prompt reconsideration rather than indefinite use.
Can omega-3 restore damaged meibomian glands?
No evidence shows that omega-3 supplements reliably regenerate glands that have already undergone significant structural loss.
The Bottom Line
Omega-3 fatty acids are important nutrients, and eating omega-3-rich foods can form part of a healthy diet.
However, omega-3 supplements should not be marketed as a proven cure for dry eye.
The current evidence shows:
- Some smaller studies and meta-analyses report benefit.
- The large DREAM trial found no meaningful advantage over placebo.
- A 2024 MGD-specific trial also failed to show superior symptom relief.
- There is no agreed dry-eye dose, formulation or treatment duration.
- Supplements can cause side effects and interact with medication.
- Dietary sources are generally preferable when practical.
For selected patients, an omega-3 supplement may be considered as an optional adjunct after discussing the potential benefits, limitations and risks.
The most effective dry-eye treatment remains one that addresses the underlying problem—whether that is meibomian gland dysfunction, inflammation, reduced tear production, incomplete blinking, eyelid disease or another cause.
References
- Jones L, et al. TFOS DEWS III: Management and Therapy. American Journal of Ophthalmology. 2025.
- Dry Eye Assessment and Management Study Research Group. n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. New England Journal of Medicine. 2018.
- Hussain M, et al. The DREAM Extension Study: Withdrawal of Omega-3 Supplements in Dry Eye Disease. American Journal of Ophthalmology. 2020.
- Eom Y, et al. Re-Esterified Triglyceride Omega-3 Fatty Acids in Dry Eye Disease With Meibomian Gland Dysfunction: A Randomised Clinical Trial. JAMA Ophthalmology. 2024.
- Wang WX, et al. Efficacy of Omega-3 Intake in Managing Dry Eye Disease: A Systematic Review and Meta-analysis of Randomised Controlled Trials. Journal of Clinical Medicine. 2023.
- National Institutes of Health, Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals.
- Health Promotion Board, Singapore. Makan Matters: What’s a Balanced Diet?
- Health Sciences Authority, Singapore. Regulatory Overview of Health Supplements.



